All Relations between Schizophrenia and Risperidone
| Publication | Sentence | Publish Date | Extraction Date | Species |
|---|---|---|---|---|
| Rishikesh V Behere, Ganesan Venkatasubramanian, Rashmi Arasappa, Nalini Reddy, Bangalore N Gangadha. Effect of risperidone on emotion recognition deficits in antipsychotic-naïve schizophrenia: a short-term follow-up study. Schizophrenia research. vol 113. issue 1. 2009-10-12. PMID:19545977. | effect of risperidone on emotion recognition deficits in antipsychotic-naïve schizophrenia: a short-term follow-up study. | 2009-10-12 | 2023-08-12 | Not clear |
| Koksal Alptekin, Jamal Hafez, Shlomo Brook, Cengiz Akkaya, Errikos Tzebelikos, Alp Ucok, Hamdy El Tallawy, Aysen-Esen Danaci, Wing Lowe, Onur N Karaya. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study. International clinical psychopharmacology. vol 24. issue 5. 2009-10-09. PMID:19531959. | to compare the effectiveness of a switch from haloperidol (n=99), olanzapine (n=82), or risperidone (n=104) to 12 weeks of treatment with 80-160 mg/day ziprasidone in patients with stable schizophrenia or schizoaffective disorder. | 2009-10-09 | 2023-08-12 | Not clear |
| Koksal Alptekin, Jamal Hafez, Shlomo Brook, Cengiz Akkaya, Errikos Tzebelikos, Alp Ucok, Hamdy El Tallawy, Aysen-Esen Danaci, Wing Lowe, Onur N Karaya. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study. International clinical psychopharmacology. vol 24. issue 5. 2009-10-09. PMID:19531959. | in conclusion, oral ziprasidone of 80-160 mg/day with food was a clinically valuable treatment option for stable patients with schizophrenia or schizoaffective disorder experiencing suboptimal efficacy or poor tolerability with haloperidol, olanzapine, or risperidone. | 2009-10-09 | 2023-08-12 | Not clear |
| Sung-Wan Kim, Il-Seon Shin, Jae-Min Kim, Tak Youn, Su-Jin Yang, Michael Y Hwang, Jin-Sang Yoo. The 5-HT2 receptor profiles of antipsychotics in the pathogenesis of obsessive-compulsive symptoms in schizophrenia. Clinical neuropharmacology. vol 32. issue 4. 2009-10-08. PMID:19644229. | we report the development of de novo obsession induced by sequential treatment with risperidone, aripiprazole, and ziprasidone, which have an antagonist effect on serotonin 5-ht(2a) receptors in a patient with schizophrenia. | 2009-10-08 | 2023-08-12 | Not clear |
| Serge Schneider, Estelle Sibille, Michel Yegles, Hugo Neels, Robert Wennig, Annette Müh. Time resolved analysis of risperidone and 9-hydroxy-risperidone in hair using LC/MS-MS. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. vol 877. issue 24. 2009-09-24. PMID:19595645. | time resolved analysis of risperidone and 9-hydroxy-risperidone in hair using lc/ms-ms. risperidone (rsp) is a second generation anti-psychotic drug used for the treatment of schizophrenia and anxiety disorders. | 2009-09-24 | 2023-08-12 | human |
| R J Hempel, J H M Tulen, N J M van Beveren, C H Röder, M W Hengevel. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia. Journal of psychopharmacology (Oxford, England). vol 23. issue 6. 2009-09-22. PMID:18562420. | cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia. | 2009-09-22 | 2023-08-12 | human |
| R J Hempel, J H M Tulen, N J M van Beveren, C H Röder, M W Hengevel. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia. Journal of psychopharmacology (Oxford, England). vol 23. issue 6. 2009-09-22. PMID:18562420. | this study aimed to investigate the effects of treatment with haloperidol, olanzapine and risperidone on cardiovascular variability in patients with recent-onset schizophrenia by means of spectral analysis. | 2009-09-22 | 2023-08-12 | human |
| R J Hempel, J H M Tulen, N J M van Beveren, C H Röder, M W Hengevel. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia. Journal of psychopharmacology (Oxford, England). vol 23. issue 6. 2009-09-22. PMID:18562420. | we conclude that young, unmedicated patients with schizophrenia differed from controls in their parasympathetic functioning, but the antipsychotic agents haloperidol, risperidone and olanzapine induced only minor cardiovascular side effects. | 2009-09-22 | 2023-08-12 | human |
| Gaku Okugawa, Masaki Kato, Masataka Wakeno, Jun Koh, Masayuki Morikawa, Naoki Matsumoto, Kazuhiro Shinosaki, Hiroshi Yoneda, Toshifumi Kishimoto, Toshihiko Kinoshit. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study. Psychiatry and clinical neurosciences. vol 63. issue 3. 2009-09-16. PMID:19566763. | randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: kansai psychiatric multicenter study. | 2009-09-16 | 2023-08-12 | Not clear |
| J M Olivares, A Rodriguez-Morales, J Diels, M Povey, A Jacobs, Z Zhao, A Lam, J C Villalobos Vega, J Alonso Cuéllar, F J Alberca de Castro, C Morillo-Velarde Quintero, J F Román Martíin, P Tabares Domínguez, J L Prados Ojeda, S Sanz Cortés, F I Mata Cala, C Gutiérrez Marín, L Moyano Castro, M A Haza Duaso, J Requena Albarracín, G Narbona Vergara, A Fernández Benítez, F Mayoral Cleries, J M García-Herrera Pérez-Brian, A Bordallo Aragón, J C Rodríguez Navarro, J A Algarra Biedma, R Bravo de Pedro, J F Delgado González, M E Jaén López, H Díaz Moreno, J A Soto López, E Ojeda Rodríguez, C Martínez de Hoyos, M Pardilla Sacristán, M D Molina Martín, E Martín Ballesteros, P A Sopelana Rodríguez, L Fernández Menéndez, R Santos Rivas, P del Pino Cuadrado, J Correas Lauffer, J J Rodríguez Solano, J M Fernández Martínez, F García Solano, P García-Lamberde Rodríguez, J A Romero Rodríguez, T Rodríguez Cano, M Ducaju Fortacin, J M Blanco Lobeiras, J M Piñeiro Sampedro, A Pérez Bravo, A Fernández Pellicer, M D Alonso López, J Fraga Liste, M Riobo Fernández, A Casas Losada, R Vazquez-Noguerol Mendez, S Agra Romero, J J Blanco Blanco, I Tortajada Bonaselt, M C García Mahia, E Ferrer Gómez del Valle, P Quiroga Yañez, M Gelabert Camarasa, J A Barbado Alonso, G Florez Mendez, F Doce Feliz, M A López Lamela, M Vega Piñero, P Fuentes Alvarado, I López Gómez, P Fadon Martín, J L Santos Gómez, A García López, A Rodríguez Jiménez, A Escudero Nafs, N Casas Barquero, R Fernández-Villamor Ortiz, J L Velez Noguera, P Ruiz Carrasco, J Martín Muñoz, M Masegoza Palma, C Marín Hortelano, L Sánchez Bonome, J Sánchez Sevilla, J M Mongil San Juan, J M García Ramos, J L Vallejo Muñoz, J Elorza Guisasola, L Santamaria Vazquez, F Campo Guerras, F J Arrufat Nebot, F J Baron Fernández, A L Palomo Nicolau, R Catala Subirats, M Messays Kidias, V Fabregat Navarro, B Frades García, F Mejias del Rosal, T de Vicente Muñoz, J Año Ballester, P Malabia Lieb, A Delgado Martel, E Roca Bea, I Grau Joaquim, F Boatas Enjuanes, M Bañuelos Piñol, E Fontova I Carbonell, R Martín Muñoz, C Argila Giribets, L Albages Sans, A Serrano Blanco, M Arcega Felipe, P González Muñoz, A Pons Villanueva, M Bernardo Arroyo, R Coronas Borri, S Miret Fallada, M Celma Merola, E Parellada Rodon, J R Pigem Palmes, E Pérez Martínez, J Matarredona Catala, A Sandoval Coca, F Pascual Ferrandiz, E Ferrandiz Paya, G Iturri Caballero, A Franco Bonet, J Fluvia Figueras, P Moreno Pagador, M Medina Garibo, V Pérez Camo, C Sanz Carrillo, C Pelegrin Valero, F J Caro Rebollo, J García Campayo, J M Sala Sala Ayma, M Martínez Roig, M A de Uña Mateos, R García Bertolin, A Martín García, F Jiménez Mazo, J L Galvez Velasco, L Santa Maria Pérez, C Jiménez Casado, J J Mancheño Barba, M Conde Diaz, J P Alcon Rubio, A Soler Mandoli, A Uson Herrero, A Rodríguez Martínez, P Salgado Serrano, E Nieto Rodríguez, J Segui Montesinos, J Ferragud Macia, A Mateos Mateos Marcos, J V Pérez-Fuster Soto, M Verdaguer Dumont, J Parra Pagan, V Balanza Martínez, M Santiuste de Pablos, C Espinosa Delgado, M D Martínez Quiles, F J Manzanera López, P Pozo Navarro, A Micol Torres, F J Martínez Ingles, J M Salmeron Arias-Camison, J C López Manzano, R Villanueva Peña, G Petersen Guitarte, H Blasco Fontecilla, J Barjau Romero, R Sanz Gil, J Marín Lozano, L Donaire Adanez, I Zarranz Herrera-Oria, J Pérez Jiménez, F Carrato Vaz, O Sanz García, C Contreras Anton, R Reixach Casula, M C Natividad Hernandez, F Teba Escabias, J Rodríguez Torresano, A Huidobro Pérez-Villamil, L Estevez, M Aragües Figuero, A Muñoz de Morales, J L Rodríguez Calvin, M Delgado Criado, V Molina Rodríguez, E Balbo Ambrosolio, P M Holgado Madera, G Ponce Alfaro, M M Rojas Vidal, A García Valtuille, O Ruiz, G Lucas Cabornero, M Echevarria Martínez de Bujo, M J Maicas Mallen, J Santandreu Puigros, A Liñana Martorell, A Clar Forteza, E Rodríguez Arrebola, M Rodríguez de la Torre, C G Anton Saiz, C Bardolet I Casas, E Rodríguez Linde, R De Arce Cordon, E M Padial Molina, F J Ruiz Carazo, J J Muro Romero, D Vico Cano, M Soria Dorado, S Campos Velazquez, A J Rodríguez Sánchez, S Ocio Leon, K Pachas Sánchez, M Henry Benitez, A Intxausti Zugarramurai, M A Contreras, M De la Varga González, P Barreiro Marín, F Gómez Robina, M Sánchez García, F J Otero Pérez, P Cubero Bros, A Carrillo Gómez, J de Dios Molina Martín, J L Carrasco Perera, M C Averbach, J L Carrasco Perera, E Goenaga Palancares, M T Gallego de Dios, C Fernández Rojo, S Sánchez Iglesias, M I Rubio Merino, N Prieto Mestre, A Pérez Urdaniz, J M Martínez Sánchez, R Gordo Seco, J Franco Muñoz, M Mateos Agut, M L Blanco Lozano, F Martín Herguedas, A Torcal Pena, J Vicente García, A Varona Martínez, O Sanz Sanz Granado, M A Medina Fernández, J M Moran Canseco, P A Megia López, M A Franco Martín, J A Espina Barrio, J Giner Ubago, M Roca Bennassar, J M Olivares Díez, J L Hernandez Fleta, F Porras Fortes, C Arango López, O Medina, D Figuera Alvarez, J M Peña Roca, G Rubio Valladolid, J A Furquet Tavera, J A García-Castrillon Sales, I Batalla Llordes, C Anchuistegui Melgarejo, F Cañas de la Paz, V Vallés Callol, M Bousoño García, J Bobes García, F J Vaz Leal, E Cáceres Corrales, E Sánchez Iglesias, M A Carreiras Gómez, G García Serrano, E G Román Chillarón, F J Samino Aguado, J J Molina Castillo, A González González, J Gallardo Vázquez, M Bolivar Peralvarez, M Rios Diaz, M Ybarzabal Mesa, F J Acosta Artiles, M Ajoy Chao, M Ybarzabal Mesa, P del Rosario Santana, M A García Escudero, M Molla Berenguer, J M Bonete Llacer, J A Juan Berna, J Barragán Ortiz, L Tost Pardell, C Hernández-Alvarez de Sotomayor, M R Cejas Méndez, R Cabrera Garate, B Díaz Múgica, M Caballero González, J Pujol Domingo, C Sáez Navarro, G Selva Vera, M A Cuquerella, J Lonjedo Monzo, P Cervera Boada, M F Martín Pérez, E Carrasco Parrado, J J Yañez Sánchez, J Calvo Fernánde. Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR). European psychiatry : the journal of the Association of European Psychiatrists. vol 24. issue 5. 2009-09-14. PMID:19195847. | long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in spain: results from the electronic schizophrenia treatment adherence registry (e-star). | 2009-09-14 | 2023-08-12 | Not clear |
| Bun-Hee Lee, Yong-Ku Ki. Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls. Schizophrenia research. vol 104. issue 1-3. 2009-08-28. PMID:18639442. | we also determined the impact of 6-week risperidone treatment on circulating no metabolites in patients with schizophrenia. | 2009-08-28 | 2023-08-12 | Not clear |
| Axel Becker, Gisela Grecksch, Gerald Zernig, Elisabeth Ladstaetter, Christoph Hiemke, Ulrich Schmit. Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia. Psychopharmacology. vol 202. issue 4. 2009-08-11. PMID:18810393. | haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia. | 2009-08-11 | 2023-08-12 | Not clear |
| V Ryckmans, J P Kahn, S Modell, C Werner, R D McQuade, W Kerselaers, J Lissens, R Sanche. Switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues with risperidone: a randomized, multicentre, open-label study. Pharmacopsychiatry. vol 42. issue 3. 2009-08-06. PMID:19452380. | switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues with risperidone: a randomized, multicentre, open-label study. | 2009-08-06 | 2023-08-12 | Not clear |
| V Ryckmans, J P Kahn, S Modell, C Werner, R D McQuade, W Kerselaers, J Lissens, R Sanche. Switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues with risperidone: a randomized, multicentre, open-label study. Pharmacopsychiatry. vol 42. issue 3. 2009-08-06. PMID:19452380. | this study evaluated the safety/tolerability and effectiveness of aripiprazole titrated-dose versus fixed-dose switching strategies from risperidone in patients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues. | 2009-08-06 | 2023-08-12 | Not clear |
| Tatsuhiko Yagihashi, Masafumi Mizuno, Bun Chino, Yuji Sato, Kei Sakuma, Toru Takebayashi, Takahashi Takao, Kenjiro Kosak. Effects of the CYP2D6*10 alleles and co-medication with CYP2D6-dependent drugs on risperidone metabolism in patients with schizophrenia. Human psychopharmacology. vol 24. issue 4. 2009-08-05. PMID:19387994. | effects of the cyp2d6*10 alleles and co-medication with cyp2d6-dependent drugs on risperidone metabolism in patients with schizophrenia. | 2009-08-05 | 2023-08-12 | Not clear |
| Ashok Kumar Jainer, Ahmad Mahmoo. Risperidone for adolescent schizophrenia. The British journal of psychiatry : the journal of mental science. vol 194. issue 6. 2009-08-03. PMID:19478315. | risperidone for adolescent schizophrenia. | 2009-08-03 | 2023-08-12 | Not clear |
| Camilo de la Fuente-Sandoval, Rafael Favila, Patricia Alvarado, Pablo León-Ortiz, Leonardo Díaz-Galvis, Carmen Amezcua, Erik García-Muñoz, Ariel Graff-Guerrer. [Glutamate increase in the associative striatum in schizophrenia: a longitudinal magnetic resonance spectroscopy preliminary study]. Gaceta medica de Mexico. vol 145. issue 2. 2009-07-30. PMID:19518017. | to compare glutamate levels (glu) found in the dorsal-caudate nucleus (a dopamine rich region) and in the cerebellum (a low dopamine region) among: 1) schizophrenia patients undergoing an acute psychotic episode, 2) after receiving antidopaminergic treatment (risperidone), and 3) healthy controls. | 2009-07-30 | 2023-08-12 | Not clear |
| John W Newcomer, Robert E Ratner, Jan W Eriksson, Robin Emsley, Didier Meulien, Frank Miller, Julia Leonova-Edlund, Ronald W Leong, Martin Breche. A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone. The Journal of clinical psychiatry. vol 70. issue 4. 2009-06-30. PMID:19358783. | a 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone. | 2009-06-30 | 2023-08-12 | Not clear |
| John W Newcomer, Robert E Ratner, Jan W Eriksson, Robin Emsley, Didier Meulien, Frank Miller, Julia Leonova-Edlund, Ronald W Leong, Martin Breche. A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone. The Journal of clinical psychiatry. vol 70. issue 4. 2009-06-30. PMID:19358783. | this randomized, 24-week, flexible-dose study compared changes in glucose metabolism in patients with dsm-iv schizophrenia receiving initial exposure to olanzapine, quetiapine, or risperidone. | 2009-06-30 | 2023-08-12 | Not clear |
| N N Chitaia, D S Danilov, N A Tiuvin. [Peculiarities of neuroleptic syndrome in women treated with typical and atypical neuroleptics]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 109. issue 3. 2009-06-30. PMID:19365390. | tolerability of haloperidol, clozapine and risperidone has been studied in 60 women with different psychiatric disorders including schizophrenia (83,2%) and neurotic disorders (16,7%). | 2009-06-30 | 2023-08-12 | Not clear |